Key result
Sitagliptin treatment caused a significant and dose-dependent reduction in intima-media ratio in obese diabetic rats following carotid artery balloon injury.
Why the study?
Does sitagliptin reduce neointimal formation and restenosis after carotid balloon injury in a rat model of type 2 diabetes?
Does sitagliptin reduce neointimal formation and restenosis after carotid balloon injury in a rat model of type 2 diabetes?
p-value: p=<0.05
In a rat model of type 2 diabetes, sitagliptin dose-dependently reduced neointimal formation after carotid balloon injury, suggesting potential protective effects against vascular restenosis.
No takes yet. Share an insight, caveat, or question.
May attenuate neointimal hyperplasia in diabetic rat models; leaves open translation to human post-angioplasty restenosis prevention.
Lim et al. (2012) studied Neointimal formation after balloon injury in type 2 diabetes (n=60). Des-fluoro-sitagliptin vs. Normal saline was evaluated on Intima-media ratio (IMR) (p=<0.05). Sitagliptin treatment caused a significant and dose-dependent reduction in intima-media ratio in obese diabetic rats following carotid artery balloon injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: